Relation of insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection
- PMID: 21475535
- PMCID: PMC3068815
Relation of insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection
Abstract
Background: Hepatitis C virus (HCV) infection can predispose to the development of insulin resistance before diabetes occurs. Such a potential link is particularly cogent in light of recent data indicate that diabetes may be associated with increased hepatic fibrosis progression in patients with chronic HCV infection. The aim of the study is to determine the prevalence of insulin resistance in non diabetic patients with chronic hepatitis C and its relation to liver fibrosis.
Methods: Thirty eight patients with chronic liver diseases. They subdivided into 2 groups; chronic hepatitis C (CHC) with elevated liver enzymes and CHC with normal liver enzymes. Age and sex matched 12 healthy subjects as control group. All subjects were subjected to Careful history and copmlete examination with stress upon symptoms and signs of chronic liver diseases. Investigations include liver function tests; viral markers (Anti HCV antibodies & PCR for HCV). Serum fasting glucose; serum fasting insulin; homeostasis model assessment (HOMA), liver biopsy and abdominal ultrasound.
Results: No correlation between viral load and hepatic fibrosis in HCV infected patients. Liver fibrosis is considerably higher among HCV patients with elevated serum transaminase levels. Insulin resistance is present in HCV infected cases compared with control group and it is positively correlated with liver fibrosis.
Conclusion: The present data support the hypothesis that insulin resistance may increase the rate of fibrosis progression in non diabetic patients with chronic HCV. Follow up of hyperinsulinemia by serial measurement of HOMA test in non diabetic HCV infected patients may be a biochemical indicator for progression of liver fibrosis.
Figures




Similar articles
-
Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.Transl Res. 2011 Sep;158(3):155-62. doi: 10.1016/j.trsl.2011.04.005. Epub 2011 May 30. Transl Res. 2011. PMID: 21867981
-
Serum leptin and homeostasis model assessment-IR as novel predictors of early liver fibrosis in chronic hepatitis B virus infection.Br J Biomed Sci. 2018 Oct;75(4):192-196. doi: 10.1080/09674845.2018.1505187. Epub 2018 Sep 7. Br J Biomed Sci. 2018. PMID: 30079841
-
Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma.Virol J. 2011 Nov 1;8:496. doi: 10.1186/1743-422X-8-496. Virol J. 2011. PMID: 22044490 Free PMC article.
-
Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.Adv Parasitol. 2016;91:111-231. doi: 10.1016/bs.apar.2015.12.003. Epub 2016 Feb 5. Adv Parasitol. 2016. PMID: 27015949 Review.
-
Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.World J Gastroenterol. 2017 Mar 7;23(9):1697-1711. doi: 10.3748/wjg.v23.i9.1697. World J Gastroenterol. 2017. PMID: 28321170 Free PMC article. Review.
Cited by
-
Serum Mac-2 Binding Protein Glycosylation Isomer Concentrations Are Associated With Incidence of Type 2 Diabetes.J Clin Endocrinol Metab. 2023 Jun 16;108(7):e425-e433. doi: 10.1210/clinem/dgad011. J Clin Endocrinol Metab. 2023. PMID: 36638007 Free PMC article.
-
Hepatitis C Virus, Insulin Resistance, and Steatosis.J Clin Transl Hepatol. 2016 Mar 28;4(1):66-75. doi: 10.14218/JCTH.2015.00051. Epub 2016 Mar 15. J Clin Transl Hepatol. 2016. PMID: 27047774 Free PMC article. Review.
-
Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.World J Gastroenterol. 2012 May 14;18(18):2203-11. doi: 10.3748/wjg.v18.i18.2203. World J Gastroenterol. 2012. PMID: 22611313 Free PMC article. Clinical Trial.
-
Interrelationship between Toll-like receptors and infection after orthotopic liver transplantation.World J Transplant. 2020 Jun 29;10(6):162-172. doi: 10.5500/wjt.v10.i6.162. World J Transplant. 2020. PMID: 32742949 Free PMC article. Review.
-
Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters.Viruses. 2024 Feb 27;16(3):371. doi: 10.3390/v16030371. Viruses. 2024. PMID: 38543737 Free PMC article.
References
-
- Wasley A, Alter M. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin liver Dis. 2000;20(1):1–60. - PubMed
-
- EI-Sayed NM, Gomatos PJ, Rodier GR, et al. Seroprevalence survey of Egyptian tourism workers to hepatitis B virus, hepatitis C virus, human in immunodeficiency virus and Treponema pallidum infections: Association of hepatitis C virus infections with specific regions of Egypt. Am J trop Med Hyg. 1996;55:179–84. - PubMed
-
- Abdel-Wahab M, Zakaria S, Kamel M, et al. High seroprevalence of hepatitis C infection among risk groups in Egypt. Am J Trop Med Hyg. 1994;51(5):563–7. - PubMed
-
- Marcellin P, Hepatitis C. Clinical spectrum of the disease. J Hepatol. 1999;31:9–16. - PubMed
-
- Allison M, Wreghitt T, Palmer C, et al. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J hepatol. 1994;21:1135–1139. - PubMed
LinkOut - more resources
Full Text Sources